Literature DB >> 10429187

Evidence for a dynamic role for proline376 in the purine-cytosine permease of Saccharomyces cerevisiae.

T Ferreira1, C Napias, J Chevallier, D Brèthes.   

Abstract

The purine-cytosine permease (PCP), a carrier located in the plasma membrane of Saccharomyces cerevisiae, mediates the active transport of purine (adenine, guanine and hypoxanthine) and cytosine into the cell. Previous studies [Ferreira, T, Brèthes, D., Pinson, B., Napias, C. & Chevallier, J. et al. (1997) J. Biol. Chem. 272, 9697-9702] suggest that the hydrophilic segment 371-377 (-I-A-N-N-I-P-N-) of the polypeptide chain may play a key role in the correct three-dimensional structure of the active carrier. This paper describes the effects of mutations in this particular segment: a four-residue deletion, Delta374-377, and two substitutions, P376G and P376R. The Delta374-377 PCP was expressed in tiny amounts and was totally inactive. When compared with the wild-type, the P376G PCP showed slightly decreased amounts and was able to transport the bases with significantly increased affinity and decreased turnover. The P376R PCP was normally expressed and targeted to the plasma membrane; however, despite a normal number of base-binding sites [1000-1200 pmol.(mg protein)-1], this mutated carrier was completely unable to transport any of its ligands. In addition, the Kd(app) for hypoxanthine binding was completely independent of the pH (within the range 3.5-6.0), showing that the conformational change induced by ligand binding was no longer present. Our results show that the 374-377 segment is essential for the expression and activity of this carrier. They also show that the P376 residue is part of an unusual secondary structure, probably a beta-turn motif, which must play a crucial dynamic role in the translocation process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429187     DOI: 10.1046/j.1432-1327.1999.00454.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  New plasmid system to select for Saccharomyces cerevisiae purine-cytosine permease affinity mutants.

Authors:  R Wagner; M L Straub; J L Souciet; S Potier; J de Montigny
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

2.  Modeling, substrate docking, and mutational analysis identify residues essential for the function and specificity of a eukaryotic purine-cytosine NCS1 transporter.

Authors:  Emilia Krypotou; Vasiliki Kosti; Sotiris Amillis; Vassilios Myrianthopoulos; Emmanuel Mikros; George Diallinas
Journal:  J Biol Chem       Date:  2012-09-11       Impact factor: 5.157

3.  Residues in the eighth transmembrane domain of the proton-coupled folate transporter (SLC46A1) play an important role in defining the aqueous translocation pathway and in folate substrate binding.

Authors:  Srinivas Aluri; Rongbao Zhao; Andras Fiser; I David Goldman
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-08-09       Impact factor: 3.747

4.  Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

Authors:  Florence Chapeland-Leclerc; Julien Bouchoux; Abdelhak Goumar; Christiane Chastin; Jean Villard; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Proline residues in two tightly coupled helices of the sulphate transporter, SHST1, are important for sulphate transport.

Authors:  M C Shelden; P Loughlin; M L Tierney; S M Howitt
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

6.  The solute specificity profiles of nucleobase cation symporter 1 (NCS1) from Zea mays and Setaria viridis illustrate functional flexibility.

Authors:  Micah Rapp; Jessica Schein; Kevin A Hunt; Vamsi Nalam; George S Mourad; Neil P Schultes
Journal:  Protoplasma       Date:  2015-05-29       Impact factor: 3.356

7.  Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.

Authors:  Martine Florent; Thierry Noël; Gwenaël Ruprich-Robert; Bruno Da Silva; Valérie Fitton-Ouhabi; Christiane Chastin; Nicolas Papon; Florence Chapeland-Leclerc
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.